To be consistent with this, we found that there were positive correlations between the expression of EHF and HER receptors in a cohort of gastric cancers including EGFR, HER2 and HER3, particularly HER2, in a cohort of gastric cancers, as supported by the information from TGCA database. This evidence concerns the gene ERBB2 and gastric cancer.